Skip to main content
Premium Trial:

Request an Annual Quote

Altana, Definiens, Beckman, Immune Tolerance Network, Amaxa

Premium

Altana to Install Definiens Imaging Software

Altana Pharma will adopt Definiens' biomedical image-analysis software, the companies said this week.

Neither of the Germany-based companies disclosed financial terms of the deal regarding Definiens' Cellenger software.


Beckman, Immune Tolerance Network Open Cell-based Assay Core Lab

Beckman Coulter and the Immune Tolerance Network have opened a core laboratory to develop, standardize, and automate cell-based tests for clinical trials at Beckman's facility in Miami, the company said this week.

Researchers from ITN, Beckman, and investigators from the US and Europe plan to develop and validate new cellular assays of T-cell responses for monitoring immune tolerance in clinical trials. "We believe that Beckman Coulter has a special expertise in these areas and look forward to working with the company in developing a number of these assays," said Hugh Auchincloss, chief operating officer of ITN, in a statement.

The Immune Tolerance Network, based at the University of California, San Francisco, is an international research collaboration with a dozen core facilities.


Amaxa to Optimize Nucleic Acid Technology Using ATCC Cell Lines

Amaxa said this week that it has signed a deal under which it will develop and optimize protocols for its nucleofector nucleic acid transfer technology using cell lines from the American Type Culture Collection.

"It is our goal to enable our customers to genetically manipulate the cell types they consider the best experimental model," Rainer Christine, CEO of Amaxa, said in a statement. "In looking for a partner, we needed a large collection of cell lines that came with reliable authentication. ATCC was the obvious choice."

Additional terms of the arrangement were not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.